logo
Transcription of the HIV-1 LTR Is Regulated by the Density of DNA CpG Methylation
Mutational Analysis of the Amino and Carboxy Termini of the HIV-2 Tat Protein
A Dominant Epitope of HIV-1 Protease Recognized by Hamster Monoclonal Antibodies
Clinical Research Units for the Treatment of Patients with HIV Disease
Risk of Developing AIDS After Primary Acute HIV-1 Infection
A Novel Detection Assay for the Early Diagnosis of HIV-1 Infected Infants
Clinical Significance of HIV DNA in Polymorphonuclear Neutrophils from Patients with HIV Infection
Immune Function and Neuropsychological Performance in HIV-1-Infected Homosexual Men
Natural History of Hepatitis C Virus Infection in Multitransfused Hemophiliacs
Role of Nutritional Status and Weight Loss in HIV Seroconversion Among Rwandan Women
Differences Between Men and Women with HIV-Related Pneumocystis carinii Pneumonia
Survival Prognosis of HIV-Infected Patients
Purified Protein Derivative (PPD) and HIV Infection in Cali, Colombia
Endemic HTLV-II Infection Among Tobas and Matacos Amerindians from North Argentina
Persistent Lack of Human Immunodeficiency Virus Infection in Intravenous Drug Users at Very High Risk
Attitudes of Pregnant Women Toward Routine Human Immunodeficiency Virus Antibody Testing in Italy
Foreword
In Memoriam
Dedication
Neurological Disorders Related to HTLV-1 and HTLV-II
The HIV/AIDS Epidemic
Immunopathogenesis of HIV Infection
Biology of Prion Diseases
Asking the Right Questions
GENE THERAPY FOR IMMUNODEFICIENCY AND CANCER
INTRACELLULAR IMMUNIZATION AGAINST HIV–A NOVEL TREATMENT STRATEGY FOR AIDS
DIRECT GENE TRANSFER IN VIVO AND THE TREATMENT OF HUMAN DISEASE
TRANSDOMINANT REV PROTEIN INHIBITS HIV REPLICATION WITHOUT AFFECTING T CELL FUNCTION
New Strategies for Control of HIV-1 Replication
POTENTIAL APPLICATION OF GENE THERAPY TO HIV-1 INFECTION. I. [INHIBITION OF TAT FUNCTION
Potential application of gene therapy to HIV-1 infection. II. transdominant HIV-1 Gag mutants
GENE THERAPY FOR AIDS
THE TREATMENT OF HTLV-I-ASSOCIATED ADULT T-CELL LEUKEMIA (ATL) WITH GENETICALLY ENGINEERED MONOCLONAL ANTIBODIES ARMED WITH RADIONUCLIDES
CONFRONTING A MODEL OF BREAST CANCER DUAL STEM CELLS WITH THE RESULTS OF ADJUYANT THERAPY OF EARLY HUMAN BREAST CANCER
Development of a Recombinant Vaccinia-Carcinoembryonic Antigen (CEA) Vaccine for Immunotherapy of Human Carcinoma
Modern approaches to Diagnosis of Viral Infections. - Problems of Sensitivity and Specificity
Advances in the Management of AIDS-related Opportunistic infections
OLIGONUCLEOTIDES PHOSPHOROTHIOATES FOR HIV-1 THERAPY
Antlsense oligonucleotide phosphorothioates and their analogues as inhibitors of HIV-1
HIV-I REV-REV RESPONSIVE ELEMENT INTERACTION AS A TARGET FOR ANTIVIRAL THERAPY
DIFFERENTIAL ANTIVIRAL ACTIVITY OF A PHOSPHOROTHIOATE ANTI-rev ANTISENSE OLIGODEOXYNUCLEOTIDE AGAINST HIV-1
SPECIFIC HIV-1 INHIBITORS TARGETED AT THE HIV-1 RT
PREVENTION OF PRIMARY HIV-1 INFECTION BY SUBSTRATE BASED PROTEINASE INHIBITORS AND TRUNCATED SUBSTRATES
COMPARATIVE ANALYSIS OF THE HIV-1 AND HIV-2 RNASES H
THERAPY OF AIDS OR SYMPTOMATIC HIV INFECTION WITH SIMULTANEOUS OR ALTERNATING REGIMENS OF AZT AND DDI
HIGH TURN-OVER RATES AMONG HIV INFECTED BLOOD CELLS IN VIVO REVEALED BY TREATMENT WITH NUCLEOSIDE ANALOGUES
CLINICAL SIGNIFICANCE OF HIV-1 IN-VITRO RESISTANCE TO ZIDOVUDINE
Targeting Strategies For Anti-HIV-1 Ribozymes
HIV-1 TARGETED HAIRPIN RIBOZYME
Redox Regulation of NF-kB Activation and HIV transcription
ANTI-HIV-1 ACTIVITY OF CURDLAN SULFATE
A Peptide Inhibitor of HIV-1 Replication
COMBINATION ANTI-HIV THERAPY
Immunologic Approaches to the Therapy of Patients with HIV-1 Infection
In viro use of a CD4-specific monoclonal antibody in SIV mac-infected rhesus monkeys
A new strategy of vaccine therapy in HIV infected immune deficient individuals
HIGH AFFINITY ANTIBODY AND CELLULAR IMMUNITY BY POST-EXPOSURE HIV VACCINATION
HUMAN MONOCLONAL ANTIBODIES TO gp120
ANTI-HIV IMMUNOTOXINS
Therapeutic vaccination against HIV-1 in identical twins
gp160 Vaccine Therapy in An HIV-1 Infected Patient is Associated with a Fall in Viral Burden, Antigenic Shift, and Viral Regulatory Sequence Mutations
HIGH RATE OF SIMIAN IMMUNODEFICIENCY VIRUS INFECTION OF RHESUS MONKEY FETUSES VIA AMNIOTIC FLUID
PROMISCUITY FOR MHC AND INDUCTION OF BROAD CORSSREACTIVITY FOR HIV-1 ISOLATES OF A DOMINANT CTL DETERMINANT OF THE HIV-1 ENVELOPE
The role of HIV specific CTL in HIV infection
THE HIV-1 V3 LOOP CONFORMATION AND ITS GP120 CONTEXT ARE BOTH IMPORTANT FOR NEUTRALIZATION
CHARACTERIZATION OF CRYPTIC NEUTRALIZING EPITOPES OF SIVAGM GP120 EXPOSED UPON RECEPTOR BINDING
EPITOPES OF HUMAN AND CHIMPANZEE MONOCLONAL ANTIBODIES (MAbs) WITH ANTI-VIRAL ACTIVITY AGAINST HIV-1
GLYCOSYLATION OF HIV-1 ENVELOPE PROTEIN
β-2 Microglobulin is Bound to HIV-1 and SIV, and Antibodies to β-2 Microglobulin Inhibit Infection
CHARACTERIZATION OF A CALMODULIN BINDING AND INHIBITORY PEPTIDE DOMAIN IN THE TRANSMEMBRANE PROTEIN OF HIV-1
COMPUTER STUDIES ON HIV-1 PROTEINS
NYVAC and ALVAC Vectors in Retrovirus Vaccine Development
Adeno-HIV Recombinant Vaccines
PARALLEL APPROACHES FOR THE DEVELOPMENT OF AN ANTI-SIV VACCINE
STRATEGIES FOR THE INDUCTION OF IMMUNE RESPONSES AT MUCOSAL SURFACES
Anti-HIV-1 vaccine clinical trial phase 1 using gp160 as antigen
SYNERGISTIC IMMUNITY FROM COMBINATION HIV VACCINES
Immunological Responsses in HIV-seronegative Volunteers to Live recombinant and Subunit HIV-1 Envelope Vaccines
ESTABLISHMENT OF WHO-SPONSORED FIELD SITES FOR HIV VACCINE EVALUATION IN DEVELOPING COUNTRIES
PROJECTIONS FOR GLOBAL IMMUNIZATION PROGRAMMES OF POTENTIAL HIV VACCINES
Comparative Pathogenesis and Immunology in AIDS Prevention
Vaccine and Pathogenesis Studies in the SIV Macaque Model
Components of a Formalin-Inactivated Whole Virus Vaccine Confer Broad-Spectrum, Long-lasting Protection against Both Cell-Free and Cell-Associated SIV
VACCINATION OF CYNOMOLGUS MONKEYS AGAINST HIV-2
Infection Of Macaca nemestrina By Human Immunodeficiency Virus Type 1
CHARACTERIZATION OF GROUP-SPECIFIC ANTIBODIES GENERATED BY LENTIVIRUS INFECTION OR SUBUNIT IMMUNIZATION IN PRIMATES
NEUTRALIZATION OF PRIMARY HIV-1 ISOLATES BY SERA FROM PRIMATES IMMUNIZED WITH RECOMBINANT HIV-SF2 GP120
Environmental Adaptation of HIV genomes
IDENTIFICATION OF MULTIPLE GENETIC SUBTYPES OF HIV-1 AND EVIDENCE FOR GEOGRAPHIC DISPERSAL
MOLECULAR AND BIOLOGIC TRANSITIONS FROM ACUTE TO CHRONIC HIV-1 INFECTION
DETECTION OF HIGHLY DIVERGENT HIV STRAINS IN INDIA
BIOLOGICAL AND ANTIGENIC VARIATION OF PRIMATE LENTIVIRUSES IN HUMANS AND IN EXPERIMENTALLY INFECTED MACAQUES
CHARACTERIZATION OF MACROPHAGE-COMPETENT BIOLOGICALLY ACTIVE MOLECULAR CLONES OF HIV-1
VARIATION IN THE BIOLOGICAL PROPERTIES OF HIV-1 ENVELOPE CHIMERAS
Identification of individual amino acids within the V3 region determining syncytium formation and replication rate of viruses chimeric for V3
Clinical Applications of Angiogenesis Research
THE TRANSCRIPTION FACTOR c-ets-1 IS INDUCED IN ADJACENT FIBROCYTIC STROMA SURROUNDING INVASIVE HUMAN CARCINOMAS
APPROACHES TO THE IDENTIFICATION, SYNTHESIS AND MODELLING OF NATURAL LIGANDS FOR ELAM-1
THE BIOLOGY OF VASCULAR ENDOTHELIAL GROWTH FACTOR
Effects of a novel, bacteria-derived angiostatic polysacharide on angiogenesis and tumor growth
THE FIRST KAPOSI'S SARCOMA (KS)-DERIVED CELL LINE (KS Y-1)
RELEASE AND ANGIOGENIC PROPERTIES OF EXTRACELLULAR HIV-1 TAT PROTEIN
Evidence for HIV1 Tat Receptor Expression in Kaposi Sarcoma (KS) Cell Strains and KSY-1 Cell Line
THE RGD MOTIF AND THE INTEGRIN RECEPTORS ARE INVOLVED IN THE VASCULAR CELL GROWTH AND ADHESION PROPERTIES OF EXTRACELLULAR HIV-1 TAT PROTEIN
Activity of Retinoic Acids in AIDs-related Kaposi's Sarcoma
Response of AIDS-KS Derived Cells to LIF,IL-6 and Oncostatin-M
Recombinant Oncostatin M Fusion Protein Stimulates the Growth of AIDS Related Kaposi's Sarcoma (KS) Cells
PDGF and Oncostatin-M
THE ETS FAMILY OF GENES
GENES CONTROLLING TUMOR METASTASIS
INTERACTION OF TRANSFORMED CELLS WITH HOST-DERIVED FACTORS MAY DETERMINE THEIR TUMORIGENICITY AND MALIGNANCY PHENOTYPE
HBV as a Pathogenic Factor in the Development of Hepatocellular Carcinoma
ANALYSIS OF THE P53 TUMOR SUPPRESSOR IN HTLV-I TRANSFORMED CELLS
A Novel Function for the Candidate Oncoprotein Bcl-3
THE MAXIMAL EXPRESSION OF MAMMALIAN GENOME THE COMPLEXITY OF TUMOR-SPECIFIC TRANSCRIPTS AND THE CLONING OF TUMOR-SPECIFIC cDNAs
IMMUNOPATHOGENESIS OF HIV INFECTION
A MODEL OF HIV HOMOLOGOUS VIRAL INTERFERENCE NOT MEDIATED BY THE CD4 DOWN REGULATION
HLA ALLELES ASSOCIATED WITH RELATIVE RATES OF DISEASE PROGRESSION AND DIFFERENT AIDS DIAGNOSIS IN HIV-1 INFECTED INDIVIDUALS
THE BLOCKING OF SLOW/LOW TYPE HIV REPLICATION IN CD4+ CELL LINES TAKES PLACE AFTER PROVIRUS FORMATION
INCREASED HIV-1 EXPRESSION CORRELATES WITH DEVELOPMENT OF DISEASE
DECREASED INFECTIVITY OF HIV-2 COMPARED TO HIV1
TAT PROTEIN STIMULATES THE PRODUCTION OF TRANSFORMING GROWTH FACTOR β1 (TGF - β1) BY BONE MARROW MACROPHAGES
The role of TH1 and TH2 cytokines in HIV-induced T helper cell dysregulation
EFFECT OF RECOMBINANT CD4-IgG ON IN VITRO HELPER T CELL FUNCTION
CYTOKINE-DEPENDENT AND INDEPENDENT CONTROL OF HIV TRANSCRIPTION IN PERSISTENTLY INFECTED CELL LINES
Elevated levels of TNF-α and IL-6 in plasmas from North American infants
CYTOKINE-INDUCED CELL DEATH AND EXPRESSION OF HIV-1. DO TUMOR NECROSIS FACTOR-α (TNF-α) AND INTERFERON-γ (IFN-γ) SELECTIVELY KILL HIV-INFECTED CELLS?
Relationships Between HIV-1 Expression and Cell Cycle
TEMPORAL ASPECTS OF HIV DNA AND RNA SYNTHESIS AND TISSUE DISTRIBUTION DURING HIV INFECTION
Mechanism of HIV-1 induction from chronically infected promonocytic cells by cigarette smoke constituents, benzo(a)pyrene and NNK
HIV-1 PRODUCTIVE INFECTION IN NON-PROLIFERATING CELL LINES
Molecular genetic analysis of Epstein-Barr Virus genes in lymphocyte growth transformation
EPSTEIN-BARR VIRUS-INDUCED DISEASES IN IMMUNE DEFICIENT PATIENTS WITH X-LINKED LYMPHOPROLIFERATIVE DISEASE
A Herpesvirus Vector for T-Cell Transforming Oncogenes
THE ROLE OF HUMAN HERPERVIRUS-6 IN CHRONIC POST-INFECTIOUS FATIGUE SYNDROME
HUMAN HERPERVIRUS SIX INFECTION OF MONOCYTES AND MACROPHAGES
Rosai-Dorfman Disease
Differential effects of human herpesvirus-6 infection on cytokine synthesis by T lymphocytes
CYTOPATHIC INFECTION OF NATURAL KILLER (NK) CELLS BY HIV-6
HUMAN HERPESVIRUS 7 (HHV-7) IS RELATED TO BUT SIGNIFICANTLY DIFFERENT FROM HUMAN HERPESVIRUS 6 (HHV-6) AND HUMAN CYTOMEGALOVIRUS (HCMV)
A TRANSFORMING HHV - 6 FRAGMENT FROM THE DIRECT REPEAT REGION THAT TRANSACTIVATES HIV −1
Viruses and Hodgkin's Disease
THE HEPATITIS C VIRUS
PAPILLOMAVIRUS ONCOPROTEINS
COOPERATION OF HUMAN PAPILLOMAVIRUS (HPV), HUMAN HERPESVIRUS −6 (HHV - 6). AND HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV- 1) IN CERVICAL NEOPLASIA
DOMINANT - NEGATIVE MUTANTS AS ANTIVIRALS
New Insights From Studies of the Retroviral Enzymes With Special Emphasis On Integrase
MOLECULAR CLONING AND FUNCTIONAL CHARACTERIZATION OF AN RRE-BINDING CELLULAR FACTOR
The role of vif in replication of HIV - 1 in CD4+ T lymphocytes
POSITIVE AND NEGATIVE REGULATORY ELEMENTS IMPORTANT FOR HIV - 1 EXPRESSION
NEW INSIGHTS INTO THE MECHANISM OF ACTION OF TAT AND REV
TRANSCRIPTIONAL REGULATION OF HIV
POSTTRANSCRIPTIONAL TRANSACTIVATION BY THE HIV - 1 REV AND HTLV - 1 REX PROTEINS THROUGH A HETEROLOGOUS RNA BINDING SITE
HIV - 2 LTR AND TAT
Multiple roles of the primer binding site of HIV - 1
Interaction of the HIV - 1 Rev protein and Cellular Factors with the RRE
HIV - 1 NEF INHIBITS THE INDUCTION OF NF-kB AND AP - 1 IN HUMAN T - CELL LINES
CELLULAR LOCALIZATION OF NOVEL PROTEIN ISOFORMS ENCODED BY THE HTLV - 1 PX REGION
THE P121 PROTEIN OF HTLV - I EXHIBITS STRUCTURAL SIMILARITY TO THE E5 ONCOPROTEIN OF BOVINE PAPILLOMA VIRUS AND BINDS THE 16K COMPONENT OF VACUOLAR H + ATPase
Rev of HIV - 1 and Rex of HTLV - I rescue unstable cellular mRNAs
TRANSACTIVATION OF THE PARATHYROID HORMONE. RELATED PROTEIN GENE PROMOTER BY THE HTLV-I AND HTLV-II TAX PROTEINS
INTERACTION OF CELLULAR PROTEINS WITH THE CIS-ACTING REPRESSIVE SEQUENCE (CRS) WITHIN THE HTLV - II REX-RESPONSIVE ELEMENT
C-rel Family Gene Expression in HTLV - I Infected Cells and C-rel Activation by Tax Protein
HIV/SIV
SPATIAL VISUALIZATION OF MATURING CORE OF HIV
FACTORS REGULATING THE SPONTANEOUS INACTIVATION OF HIV AND ITS SUSCEPTIBILITY TO NEUTRALIZATION
EXPRESSION OF AN ANTI-GP41 RECEPTOR ON THE SURFACE OF A B CELL ASSOCIATED WITH ENHANCED REPLICATION OF HIV-1
KINETICS OF HIV-1 ENV-MEDIATED CELL FUSION
CALCIUM IONS ARE REQUIRED FOR CELL FUSION MEDIATED BY THE CD4-HIV-1-ENVELOPE GLYCOPROTEIN INTERACTION
Defining Multi-site Interactions Between HIV-1 Gp120 and CD4 During Viral Entry and Fusion
Binding Interactions Between Peptides Corresponding to the CDR3 Region of CD4 and HIV-1 Gp120 as Studied by Biospecific Interaction Analysis
HIV-1 ENVELOPE GLYCOPROTEIN MEDIATED CELL FUSION
A CONFORMATIONAL CHANGE IN CD4 INDUCED BY BINDING OF THE HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE PROTEIN GP 120 MEDIATES VIRAL FUSION
PHOSPHOROTHIOATED ANTISENSE OLIGODEOXYNUCLEOTIDES DIRECTED AGAINST THE vpr GENE INHIBIT HIV-1 REPLICATION IN PRIMARY HUMAN MACROPHAGES
BLOCK OF HIV-1 GENE EXPRESSION BY COMBINING ANTISENSE TAT RNA AND POLY - TAR DECOY
LIPOSOMAL DELIVERY OF ANTISENSE OLIGONUCLEOTIDES
N-ACETYL-CYSTEINE (NAC) IS A POTENT SUPPRESSOR OF HIV TRANSCRIPTION IN PERSISTENTLY INFECTED MONOCYTIC CELLS
AZT RESISTANCE IS ASSOCIATED WITH DECREASED SUSCEPTIBILITY TO OTHER DIDEOXYNUCLEOSIDES (ddN)
PCR DETECTION OF AZT RESISTANCE MUTATION IN HIV-1 INFECTED HEMOPHILIACS
INHIBITION OF HIV-1 WITH NIACIN
CD-4-Pseudomonas Exotoxin Potently Inhibits Primary HIV-1 Isolates Refractory to Neutrallzation by Soluble CD4
OPTIMIZING THE DESIGN OF EXPERIMENTS ON COMBINATION THERAPY
Inhibition of Bovine Immunodeficiency-like Virus (BIV) in Cell Culture by Anti-HIV-1 Compounds,
COMPARING THE HUMORAL RESPONSE IN HIV-1 INFECTED PATIENT VOLUNTEERS POST GP-160 OR GP120 IMMUNIZATION BY PEPSCAN,
Inhibition of HIV-1 replication by a novel family of short modified peptidas
Determining Biologically Relevant Neutralization Parameters of Human Immunodeficiency Virus Type-1 Through Physicochemical Analysis
LOSS OF A NEUTRALIZING EPITOPE BY A SPONTANEOUS POINT MUTATION IN THE V3 LOOP OF HIV-1 iiib ISOLATED FROM AN INFECTED LABORATORY WORKER
Update on Retroviral Proteinases
LETHAL MUTATION IN THE V3 LOOP OF HIV-1 gp120 IS OVERCOME BY REVERSION IN TISSUE CULTURE
PRODUCTION OF FUNCTIONALLY DEFECTIVE HIV-1 REVERSE TRANSCRIPTASE CAN BE INITIATED BY A HUMAN PERIPHERAL BLOOD MONONUCLEAR CELL FACTOR
“SINGLE-HIT” ANTIBODY KINETICS
MAPPING OF A VIRUS - NEUTRALIZING SITE ON THE ENVELOPE OF FELINE IMMUNODEFICIENCY VIRUS
MULTIPLE DETERMINANTS ON THE HIV - 1 ENVELOPE CONTROL HIV - 1 INDUCED SYNCYTIUM FORMATION
Differences in release of IFN-γ by T cells of HIV - 1 - infected or rgp 160-immunized and protected chimpanzees upon stimulation with viral antigen
Interleukin 7 (IL7) enhances generation of cytolytic T lymphocytes (CTL) in HIV-1 infected individuals
Cross Neutralization of HIV-1 Isolates from Northern Thailand and the United States in a Human Peripheral Blood Mononuclear Cell Assay
HIV variability in genetically identical children with a common source of infection
BIOSYNTHESIS OF HIV-1 ENVELOPE PROTEINS IN NORMAL AND NEOPLASTIC T CELLS AND MACROPHAGES
Escape of HIV - 1 from Immune Pressure
PRODUCTION AND MODULATION OF CYTOKINES BY AIDS-KS CELLS GROWN IN ONCOSTATIN M
HIV-I TAT TURNS INTO PRODUCT CATALYZING ELECTRON TRANSFER REACTIONS IN PRESENCE OF CERTAIN SMALL METAL-SCAVANGER PEPTIDES
ADMINISTRATION OF PENTOSAN POLYSULFATE TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSI'S SARCOMA (KS)
RELEASE, UPTAKE AND BIOLOGICAL EFFECTS (VASCULAR CELL GROWTH AND VIRAL TRANSACTIVATION) OF EXTRACELLULAR HIV - 1 TAT PROTEIN
IMMUNOACTIVATION RATHER THAN IMMUNODEFICIENCY MAY COOPERATE WITH HIV - 1 INFECTION IN THE DEVELOPMENT OF AIDS-ASSOCIATED KAPOSI'S SARCOMA
STUDIES ON THE VASCULAR CELL GROWTH EFFECT OF EXTRA-CELLULAR HIV-1 TAT PROTEIN DURING THE CELL CYCLE
KAPOSI'S SARCOMA INDUCED VASCULAR CELL INVASION
ESTABLISHMENT AND CHARACTERIZATION OF AIDS-AND NON-AIDS-ASSOCIATED CUTANEOUS KAPOSI SARCOMA CELL LINES
INFLAMMATORY & ANGIOGENIC CYTOKINES IN THE PATHOGENESIS OF AIDS ASSOCIATED KAPOSI'S SARCOMA
HOST RANGE OF HIV - 1 IS ENLARGED TO TS AND B-LYMPHOCYTES IN PATIENTS CO - INFECTED BY HIV - 1 AND HTLV - II
HOMOLOGOUS SUPERINFECTION OF HIV-1-INFECTED CELLS IS BLOCKED AT A LATE RETROTRANSCRIPTION STEP
LOW-Level, Persistent HIV-1 Infection of Mammary Epithelial Cells in Vitro
LIMITING DILUTION ANALYSIS OF INTERLEUKIN 2− PRODUCING T CELLS RESPONSIVE TO RECALL AND ALLO ANTICENS IN HUMAN IMMUNODEFICIENCY VIRUS (HIV)-INFECTED AND UNINFECTED INDIVIDUALS
BRUCELLA ABORTUS AND LIPOPOLYSACCHARIDE FROM BRUCELLA ABORTUS INDUCE THI-LIKE RESPONSES IN UNINFECTED AND HIV-1-INFECTED PERSONS
Activation-induced apoptosis in HIV-transfected Jurkat cells
M. GENAVENSE, A NOVEL MYCOBACTERIUM CAUSING DISSEMINATED INFECTIONS IN HIV SEROPOSITIVE PATIENTS
HUMAN HERPESVIRUS-6 IN TISSUE FROM PATIENTS WITH AIDS AND IN SERONEGATIVE INDIVIDUALS
Augmentation of HHV-6 DNA Sequences in Corneal Cells Infected with HIV-1
HIV - 1 DNA IN FIBROBLAST CULTURES INFECTED WITH URINE FROM HIV SEROPOSITIVE CYTOMEGALOVIRUS (CMV) EXCRETORS
HIV - 1 AND HHV - 6 DOUBLE EXPRESSION IN VIVO
Transactivation of HPV transforming sequences by HIV tat gene
ALTERNATIVE MECHANISMS OF FOS/JUN-MEDIATED REGULATION OF THE HIV - 1 LONG TERMINAL REPEAT
BIOLOGICAL AND MOLECULAR PROPERTIES OF HIV - 1 INTEGRASE DEFECTIVE MUTANTS
CYTOKINE ACTIVATION DURING HIV - 1 INFECTION
HTLV - I TAX1 AND ETS1 TRANSACTIVATION OF THE HTLV - 1 LTR
HTLV-I TAX1 INCREASES THE EXPRESSION OF THE PARATHYROID HORMONE-RELATED PROTEIN GENE
IMMUNOLOCALIZATION OF HIV - 1, REV AND RRE
ALTERNATIVELY SPLICED mRNSs OF HUMAN T - LYMPHOTROPIC VIRUS TYPE I (HTLV-I)
TAT TRANSACTIVATES HUMAN IMMUNODEFICIENCY VIRUS TRANSCRIPTION IN VITRO BY STIMULATING INITIATION AND ELONGATION
Rev-Dependent Transactivation of gp160 Expression in Drosophila melanogaster S2 cells
Identification of an interferon-inducible gene inhibiting HIV-1 expression
HIV-1 Genes in the Establishment of Persistence
TUMORIGENIC PROPERTIES OF A HTLV - I TRANSFORMED HUMAN PBL IN SCID MICE
LACK OF CORRELATION BETWEEN CHANGES IN THE HTLV-1 ENV GENE SEQUENCE AND DIFFERENT NEUROLOGICAL DISEASES
EXPRESSION OF COMPLEMENT RECEPTOR 2 (CR2) ON HTLV-I INFECTED LYMPHOCYTES AND TRANSFORMED CELL LINES
HIV REPLICATIVE INTERMEDIATES IN ACUTELY INFECTED CELLS
FUSION OF HUMAN B CELLS WITH HIV-1 ENVELOPE EXPRESSING T CELLS IS ENHANCED BY ANTIGEN SPECIFIC IMMUNOGLOBULIN (IG) RECEPTORS
NEF MODIFIES MURINE T CELL FUNCTION
CROSSLINKING OF CD4 BY HIV gp120/ANTI-gp129 ANTIBODY INSOLUBLE COMPLEXES ENHANCES T CELL ACTIVATION
HTLV-I induced syneytia formation in lymphoid cell lines
IN VITRO INFECTION OF HUMAN MACROPHAGES BY HUMAN T-CELL LEUKEMIA VIRUS TYPE I
ROLE OF RECEPTOR IN HIV-1 INFECTION OF TRANSFORMED RABBIT CELL LINES
NUCLEIC ACID SEQUENCE OF RABBIT ADAPTED HIV-1
Expression of the HIV-1 LTR in Transgenic Mice is NF-kB Dependent
HYPERKERATOTIC SKIN DISORDERS IN HIV-TRANSGENIC MICE ARE ASSOCIATED WITH INCREASED TRANSGENE EXPRESSION
PATHOGENESIS OF STLV-1 INFECTION IN BABOONS
MOLECULAR CHARACTERIZATION OF STLV-1-POSITIVE LYMPHOMAS IN BABOONS (PAPIO HAMADRYAS)
HIV INFECTION IN RUSSIA
Detection of Human T- Cell Lymphotropic Virus type-II (HTLV-II) in the Breast Milk of HTLV-II Infected Mothers Using the Polymerase Chain Reaction
MOTHER TO CHILD DIFFERENTIAL HIV TRANSMISSION
DETECTION OF HIV-1 PROVIRAL SEQUENCES AND PLASMA VIRAKNIA IN HIV-1 SKNONGATIVE INDIVIDUALS AT HIGH RISK FOR AIDS
ABSENCE OF HTLV SEQUENCES IN HEALTHY INDIVIDUALS FROM APULIA (ITALY SELECTED FOR THEIR SEROREACTIVITY
MOLECULAR CHARACTERIZATION OF HUMAN T-CELL LEUKEMIA VIRUS, TYPE II (HTLV-II) ISOLATES
IN VIVO CELLULAR TROPISM OF HUMAN T-CELL LEUKEMIA VIRUS, TYPE II (HTLV-II)
MORTALITY IN THE NEW JERSEY IVDA COHORT STUDY
A TARGET POPULATION FOR AIDS INTERVENTION STUDIES II. NORTHWEST TANZANIA
The Epidemiology of HTLV-II
Improved Characterization Using Peptide-Based Assays of HTLV1− and HTL V2-Reactive Serologies in a New World Region
EPIDEMIOLOGY OF HIV AND HTLV-1 VIRUSES IN HAWAII AND THE PACIFIC ISLANDS
“SILENT” HIV INFECTION IN FIRST DEGREE RELATIVES OF HIV SEROPOSITIVE ETHIOPIANS
TAT DETECTION ASSAY BY LUMINESCENCE
SERODIAGNOSIS OF HIV BY RECOMBINANT ENV AND VPX/VPU PEPTIDES
Detection and affinity purification of LamB hybrid proteins by an anti-LamB monoclonal antibody
DEVELOPMENT AND VALIDATION OF QUANTITATIVE PCR ASSAYS TO ACCURATELY ASSESS THE AMOUNT OF HIV-1 DNA/RNA IN BLOOD CELLS FROM PATIENTS UNDERGOING A ONE YEAR IMMUNOTHERAPEUTIC TREATMENT
USE OF PCR-DEIA TO IDENTIFY HTLVI AND HTLVII INFECTIONS IN ITALIAN IVDUs, AND OTHER GROUPS
DETECTION AND QUANTIFICATION OF HIV-1 RNA USING THE ISOTHERMAL NUCLEIC ACID SEQUENCE BASED AMPLIFICATION (NASBA) TECHNOLOGY
A perspective on ELISA based quantitative HIV-1 gp120 and P-24 assays
HIV-p24 ANTIGEN IN BODY FLUIDS
Peripheral blood collected from a pigmey population on paper spot allow to analyze CD4 polimorphism by PCR amplification
Nested PCR for HIV with Single Closed Reaction Tubes
IMPROVED p24 ANTIGEN DETECTION AFTER IMMUNE COMPLEX CHEMICAL DISSOCIATION
Definition of interactions between retroviruses and the Rpt-1 gene that may regulate T-cell differentiation
THE HIV gp120 BINDING SITE ON CD4
The Interferon Receptors
NUCLEAR IMPORT OF HIV-1 PREINTEGRATION COMPLEXES AND ITS CELL-CYCLE DEPENDENCE
INCOMPLETE HIV-1 VIRAL DNA IN MATURE VIRIONS AND QUIESCENT LYMPHOCYTES
EFFECTS OF HIV-1 GP120 ON DEVELOPING AND MATURE CD4+ T CELLS
EXTRACELLULAR TAX, PROTEIN AND TAX, PRODUCING CELL LINES STIMULATE NF-KB IN UNIFECTED CELLS
REGULATION OF THE T CELL RECEPTOR IN TCR/CD3* AND TCR/CD3 WE17/10 CELLS FOLLOWING HIV-1 INFECTION
Complement-Mediated Binding of HIV-1 to CR1 and CR2
Regulation of Hematopoietic Stem Cells Defined by Quantitative Functional Assays in Vitro and in Vivo
OPPORTUNISTIC LYMPHOMAS IN SIV-INFECTED CYNOMOLGUS MONKEYS
INTERACTION OF HIV/SIV WITH LYMPH NODE FOLLICULAR DENDRITIC CELLS (FDC) OF MAN AND CYNOMOLGUS MONKEYS
A NEW SIMIAN HERPESVIRUS CLOSELY RELATED TO EBV CONTRIBUTES SUBSTANTIALLY TO THE ESTABLISHMENT OF B-CELL LYMPHOMA IN IMMUNODEFICIENT CYNOMOLGUS MONKEYS
HIV-1 Infection of Man
Repertoire Freeze of Antibodies Against HIV-1 Proteins
The borders of self-tolerance
PEPTIDE BINDING, CONFORMATIONAL CHANGES, AND INTRA-CELLULAR TRANSPORT IN THE MHC CLASS I AND CLASS II PRESENTATION PATHWAYS
Immunomodulatory effects of HIV-1 and HTLV-1 on dendritic cell (DC) function
RECOGNITION OF HIV-1-INFECTED CELLS BY CD4* T CELLS
FIBROBLAST-DERIVED FACTORS PRESERVE VIABILITY IN VITRO OF MONONUCLEAR CELLS ISOLATED FROM PATIENTS WITH AIDS
EFFECT OF INTERFERON ON THE TRANSPORT OF HIV GLYCOPROTEINS IN INFECTED MONOCYTES
HIV-INDUCED PRODUCTION OF INTERFERON-α IN PURIFIED PERIPHERAL BLOOD DENDRITIC CELLS
HIV-1 Infection of Human Stromal Cells Reprograms Cytokine Production
ESTABLISHMENT OF AN IN VITRO MODEL FOR ANTIBODY DEPENDENDENT ENHANCEMENT OF HIV INFECTION
MONOCYTE/MACROPHAGES (M/M) PRODUCE INTERLEUKIN-6 (IL-6) AND TUMOR NECROSIS FACTOR-α (TNF-α) IN RESPONSE TO GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR (GM-CSF), BUT NOT TO HIV INFECTION ALONE
INDUCTION OF HIV EXPRESSION FROM CHRONICALLY INFECTED PROMONOCYTIC AND T CELLS BY IRRADIATED HUMAN KERATINOCYTES IS MEDIATED BY TUMOR NECROSIS FACTOR-α (TNF-α) PRODUCTION
MURINE MODELS OF AIDS
A MuLV-encoded superantigen in the pathogenesis of murine retrovirus-induced immunodeficiency
T CELL RECEPTOR α AND β CHAIN EXPRESSION IN REPERTOIRE SELECTION AND IN RESPONSES TO ENDOGENOUS SUPERANTIGENS
SSAV-related human endogenous retroviral elements
ENDOGENOUS RETROVIRUS SEQUENCES EXPRESSED IN HUMAN TERATOCARCINOMA CELL LINES
A WIDE VARIETY OF HUMAN ENDOGENOUS RETROVIRAL SEQUENCES ARE EXPRESSED AS RNA IN NORMAL AND NEOPLASTIC CELLS AND MAY PROVIDE FUNDAMENTAL FUNCTIONS
INDUCTION OF A SMRV-LIKE RETROVIRUS FROM A HUMAN T-CELL LINE AFTER TREATMENT WITH THE MUTAGEN ETHYL-METHYL-SULFONATE
Characterization of a bovine cDNA corresponding to a Bovine Leukemia Virus gp51 binding protein
Development of Transgenic Mice Using Infectious Proviral Molecular Clones of the Bovine Immunodeficiency-like Virus (BIV)
Genetic, antigenic and biological characteristics of SIVopz-ant isolates, derived from a naturally infected chimpanzee
“PCR ISOLATION” OF A BIOLOGICALLY UNIQUE HIV-2 STRAIN FROM UNCULTURED PBMC DNA
INTERACTION OF SIVsmmPBj14 WITH SIMIAN LYMPHOID CELLS
Development of SIVagm and HIV-1 quasi species in vivo after infections with molecular and biological clones, respectively
Pathogenesis of SIV mac251 After Atraumatic Inoculation of the Rectal Mucosa in Rhesus Monkeys
CEREBROCORTICAL GLIOSIS IN SIV-INFECTED RHESUS MACAQUES WITH MOTOR AND COGNITIVE IMPAIRMENTS
Collapse in CD4+ Population in LN of SIV-Infected Macaques Predicts Progression to AIDS
Transgenic Mice as Models for HIV Pathogenesis and Therapy
Effects of HIV Infection in Human Thymus in the SCID-hu Mouse
ACUTE FULMINANT STAGE ADULT T-CELL LEUKEMIA/LYMPHOMA IN RABBITS INOCULATED WITH AN HTLV-1 TRANSFORMED RABBIT CELL LINE
PRIONS AND NEURODEGENERATIVE DISEASES
Neurological Disorders Related to HTLV-1 and HTLV-II
ACTIVATION EVENTS INDUCED BY HTLV-1
ANALYSIS OF HIV-HOST CELL INTERACTIONS BY SINGLE CELL TECHNOLOGIES
Effects of virus-inducing and -suppressive agents on HIV-1 production in chronically infected glial cells
HIV-1 STIMULATES CYTOKINE EXPRESSION IN PRIMARY ASTROCYTES
Limited Genetic Variation of HIV-1 in the Brain
HIV-1 GENE EXPRESSION IN NEURONAL AND GLIAL-DERIVED CELLS
Analysis of human neuroblastoma cell proliferation and differentiation on extracellular matrix protein. The role of TAT basic peptide
MOLECULAR EPIDEMIOLOGY OF HTLV-I
Complete nucleotide sequence of a Highly divergent HTLV-1 isolate from melanesia
GENETIC SEGREGATION OF ATL AND HAM/TSP IN JAPANESE AND COLOMBIAN PATIENTS
A WIDE SPECTRUM OF SIMIAN T-LYMPHOTROPIC/ LEUKEMIA TYPE I VIRUS VARIANTS IN NATURE
MATERNAL-INFANT TRANSMISSION OF HTLV-1
Further Studies in Infective Dermatitis of Jamaican Children
HIV-ASSOCIATED CANCERS IN WOMEN
HIV-1 INCIDENCE RATES IN HIGH RISK POPULATIONS
Preparations for HIV Vaccine Efficacy Trials
HIV-1 AND HTLV-I IN HAITI
HETEROGENEITY IN SUSCEPTIBILITY TO HIV-1
PORTRAIT OF THE HIV/AIDS EPIDEMIC IN WASHINGTON, D.C
UPDATE ON THE INTERNATIONAL REGISTRY OF HIV-EXPOSED TWINS
DIFFERENCES BETWEEN HIV1 AND HIV2 DYNAMICS IN FEMALE SEX WORKERS IN SENEGAL
HIV-1, NOT HIV-2, IS PREVALENT IN NIGERIA
ADDISON-LIKE SYNDROME ASSOCIATED WITH HYPERCORTISOLEMIA, GLUCOCORTICOID RESISTANCE AND HIGH LEVELS OF αINTERFERON IN AIDS PATIENTS
HIV V3 SEQUENCE ANALYSIS OF THE DENTAL CLADE AND SURROUNDING FLORIDA COMMUNITY